SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?


To: cirrus who wrote (908)7/24/1999 1:35:00 PM
From: LTK007  Read Replies (1) | Respond to of 2515
 
Article 5 of 47
Kvaerner awarded ImClone contract

07/09/1999
Chemical Business NewsBase: The Chemical Engineer
Page 10
Copyright (C) 1999; Source: World Reporter (TM)



Kvaerner has won a $40 M contract to erect a biopharmaceutical plant for
ImClone Systems at Branchburg, NJ.

The plant will produce cancer drug C-225 monoclonal antibody, which is
currently in Phase III.